Bruker Corporation (BRKR)
Return on total capital
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Earnings before interest and tax (EBIT) | US$ in thousands | 253,100 | 561,300 | 429,100 | 404,400 | 236,600 |
Long-term debt | US$ in thousands | 2,061,800 | 1,160,300 | 1,200,500 | 1,221,800 | 842,300 |
Total stockholders’ equity | US$ in thousands | 1,781,200 | 1,377,200 | 1,113,800 | 1,070,500 | 961,200 |
Return on total capital | 6.59% | 22.12% | 18.54% | 17.64% | 13.12% |
December 31, 2024 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $253,100K ÷ ($2,061,800K + $1,781,200K)
= 6.59%
The return on total capital for Bruker Corporation has shown fluctuations over the years as per the provided data. In December 2020, the return on total capital was 13.12%, which increased to 17.64% by December 2021. The trend continued to improve in the following years, reaching 18.54% in December 2022 and further increasing to 22.12% by December 2023.
However, there was a notable decline in the return on total capital by December 2024, decreasing to 6.59%, signaling a potential decrease in the company's efficiency in generating returns relative to its total capital employed. It is important for Bruker Corporation to closely monitor and address the factors contributing to this decline in order to maintain sustainable and profitable operations in the future.
Peer comparison
Dec 31, 2024